INZY - Balance Sheet - Inozyme Pharma, Inc.

Current Liabilities	33.9 M
Accounts Payable	2.53 M
Short-Term Debt	15.4 M
Other Current Liabilities	16 M
Non-Current Liabilities	31.5 M
Long-Term Debt	0
Other Non-Current Liabilities	31.5 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	21.1	34.6	32.9	23.3	159.9	31.6	36.0
Short Term Investments	92.0	154.0	95.0	88.5	119.7	15.5	7.2
Receivables	0	0.4	0.1	62 K	0.2	0.1	31 K
Inventory	0	0	(0.1)	62 K	(12.4)	0	0
Other Current Assets	0.3	7.3	3.4	3.5	3.1	0.2	73 K
Total Current Assets	120.7	196.2	131.4	115.3	151.0	47.5	43.3
PP&E	1.3	2.6	3.6	4.4	2.6	0.3	0.2
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	0.4	0.4	12.2	0.1	0
Other Long Term Assets	1.2	2.0	3.8	3.4	3.5	56 K	34 K
Other Assets	0	0	0	0	0	0	0
Total Assets	123.2	200.8	139.2	123.5	169.4	47.9	43.5
LIABILITIES
Accounts Payable	2.5	1.2	2.5	2.4	3.1	0.9	1.0
Short Term Debt	15.4	0.9	1.6	1.5	0	0	0
Other Current Liabilities	16.0	12.6	10.5	7.8	6.9	2.3	1.4
Total Current Liabilities	33.9	14.7	14.7	11.6	10.0	3.2	2.4
Long Term Debt	0	45.7	6.0	2.6	1.3	0	0
Deferred Tax Income	0	0	0	0	0	0	0
Other Liabilities	0	0	0.1	0	0	0	55.0
Total Liabilities	65.4	60.4	20.8	14.3	11.3	81.2	57.4
EQUITY
Common Stock	6 K	6 K	4 K	2 K	2 K	1 K	1 K
Retained Earnings	(388.0)	(285.9)	(214.8)	(147.7)	(91.1)	(34.7)	(14.9)
Other Accumulative Comprehensive Income/Loss	69 K	41 K	(0.2)	18 K	2 K	5 K	2 K
Total Equity	57.8	140.5	118.6	109.3	158.1	(33.2)	(13.9)
Total Liabilities and Equity	123.2	200.8	139.4	123.5	169.4	47.9	43.5
SHARES OUTSTANDING
Common Shares Outstanding	62.8	51.8	37.8	23.6	23.4	15.2	15.1

Free